Halstead Michael

Average Profitability
67.15%
Insider Buys Quantity
2
Insider Buys Sum
$615,160.00
Insider Sells Quantity
29
Insider Sells Sum
$29.42M

Insider Activity of Halstead Michael

According to the SEC Form 4 filings, Halstead Michael, being in a position of

  1. EVP and General Counsel at Intra-Cellular Therapies, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 90244 shares for $6.03M,
    over all time since 2014-11-05, has bought 40000 shares for $615,160, and sold 751644 shares for $29.42M.

The largest purchase of all time was on 2014-11-06 and amounted to 26000 shares of Intra-Cellular Therapies, Inc. for $402,220.

The largest sale of all time was on 2021-12-21 and amounted to 176863 shares of Intra-Cellular Therapies, Inc. for $8.41M.

Biography of Halstead Michael

No biography is available at this moment.

2024-03-11SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,345
0.0076%
$65.97$484,537+10.75%
2024-03-07SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
13,132
0.0134%
$66.15$868,698+8.53%
2024-02-26SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,907
0.0079%
$69.53$549,784+1.03%
2024-02-02SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,860
0.012%
$66.42$787,719+7.45%
2024-01-11SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
50,000
0.0513%
$66.83$3.34M+5.48%
2023-03-13SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,344
0.0077%
$44.94$330,007+35.93%
2023-03-10SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
16,708
0.0172%
$43.10$720,086+38.64%
2023-02-24SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,906
0.0083%
$47.03$371,819+27.97%
2023-02-21SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
1,200
0.0013%
$48.76$58,508+29.6%
2023-02-21SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,139
0.0118%
$46.84$521,699+29.6%
2022-12-01SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
50,000
0.053%
$53.73$2.69M+3.46%
2022-02-24SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,906
0.0083%
$51.98$410,933-2.17%
2022-02-22SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,139
0.0122%
$55.40$617,100-3.92%
2022-01-10SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
19,639
0.0211%
$40.77$800,774+29.07%
2021-12-21SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
176,863
0.2148%
$47.56$8.41M+9.7%
2021-02-19SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,139
0.0137%
$39.24$437,133-4.23%
2021-01-11SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
19,638
0.0243%
$32.03$628,978+15.93%
2021-01-04SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
16,160
0.0197%
$31.30$505,834+16.63%
2020-11-17SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
79,425
0.0985%
$27.62$2.19M+25.74%
2020-01-09SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
39,276
0.0621%
$26.16$1.03M-9.06%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.